TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06044935

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Diet
Description: Consisting of 15% protein, 35% fat, and 50% carbohydrate, matching the macronutrient composition of a typical American diet

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Diet
Description: Consisting of 15% protein, 35% fat, and 50% carbohydrate, matching the macronutrient composition of a typical American diet

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Diet
Description: Consisting of 15% protein, 35% fat, and 50% carbohydrate, matching the macronutrient composition of a typical American diet

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Consisting of a macronutrient composition of 15% protein, 80% fat, and 5% carbohydrate

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Consisting of a macronutrient composition of 15% protein, 80% fat, and 5% carbohydrate

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: Consisting of a macronutrient composition of 15% protein, 80% fat, and 5% carbohydrate

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects without MODY2 will take either placebo or NR (1 g BID, 2 g per day total) supplements for 7 days during this Run-in phase

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects without MODY2 will take either placebo or NR (1 g BID, 2 g per day total) supplements for 7 days during this Run-in phase

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects without MODY2 will take either placebo or NR (1 g BID, 2 g per day total) supplements for 7 days during this Run-in phase

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside
Description: Subjects without MODY2 will take either placebo or NR (1 g BID, 2 g per day total) supplements for 7 days during this Run-in phase

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nicotinamide Riboside
Description: Subjects without MODY2 will take either placebo or NR (1 g BID, 2 g per day total) supplements for 7 days during this Run-in phase
Study: NCT02579187

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: tooth extraction
Description: The study tooth will be removed

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: tooth extraction
Description: The study tooth will be removed

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CBCT scan
Description: a CBCT scan limited to the dental arch that includes the study side will be obtained

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CBCT scan
Description: a CBCT scan limited to the dental arch that includes the study side will be obtained

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CBCT scan
Description: a CBCT scan limited to the dental arch that includes the study side will be obtained

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: CBCT scan
Description: a CBCT scan limited to the dental arch that includes the study side will be obtained

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia
Description: all subjects will receive local infiltrative anesthesia, prior to extraction of the tooth

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia
Description: all subjects will receive local infiltrative anesthesia, prior to extraction of the tooth

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anesthesia
Description: all subjects will receive local infiltrative anesthesia, prior to extraction of the tooth

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Anesthesia
Description: all subjects will receive local infiltrative anesthesia, prior to extraction of the tooth

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: clinical measurements
Description: After tooth extraction, clinical measurements of the site will be obtained and recorded (keratinized mucosa width, horizontal ridge width, facial and lingual bone thickness

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: clinical measurements
Description: After tooth extraction, clinical measurements of the site will be obtained and recorded (keratinized mucosa width, horizontal ridge width, facial and lingual bone thickness

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: clinical measurements
Description: After tooth extraction, clinical measurements of the site will be obtained and recorded (keratinized mucosa width, horizontal ridge width, facial and lingual bone thickness
Study: NCT05985824

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pranayama breathing exercise
Description: Pranayama is an important step in yoga, way of life, and is translated as the science of breathing, breath control, willful breathing. This alternating breathing-out action also balances the sympathetic and parasympathetic nervous systems, giving the person a state of calm, providing relaxation and positively affecting fatigue. Application steps; Right hand Nasika mudra is performed. Nasika mudra is the mudra where the second and third fingers of the right hand are folded into the palm and the other fingers are exposed. Then the right nostril is closed with the first finger of the right hand. Start by breathing through the left nostril. Then the left nostril is closed with the fourth finger and the breath is held. While the left nostril is closed, the right nostril is opened and inhaled. Breathe again through
Study: NCT04666857

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: early motor intervention
Description: infants with CHD after open heart surgery will receive early intervention
Study: NCT05640154

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: educational program
Description: The nursing educational program will be implemented in small groups from (5-7) in outpatient clinics. It includes nutrition, exercise, control hypertension , engage in weight control measures, smoking cessation, stress management, breathing exercise, appropriate treatment of diseases, control of diabetes, control of cholesterol in blood and routine follow up).
Study: NCT05186714

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tai Chi versus wellness education
Description: 12 weeks of Tai Chi (2x/week) or a wellness education (2x/week)

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Tai Chi versus wellness education
Description: 12 weeks of Tai Chi (2x/week) or a wellness education (2x/week)
Study: NCT05210257

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional physiotherapy
Description: Group 1 was given conventinal physiotherapy Physiotherapy agents; 5 min ultrasound 1.5 watts/cm2 20 min conventional TENS 20 min heat agent application (hot pack) Exercise program; Stretching and relaxation exercises, Neck strengthening exercises that include concentric and isometric contractions Posture exercises 3 sets per day, 1 in the hospital with 10 repetitions

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuroscience education
Description: Conventional physiotherapy program and The neuroscience education trainings will be conducted in the form of face-to-face interviews and 45-50 minute one-to-one sessions.~In sessions ; neurons and nerve conduction in the session, the formation process of pain, peripheral neuropathic pain, pain spread during the session, neuroplasticity, peripheral and central sensitization, hyperalgesia and allodynia, acute-chronic pain, The effects of stress, fear, anxiety, false thoughts and beliefs about pain and other psychosocial factors on the pain process and determining possible psychosocial factors in the patient during the session, Strategies for controlling the pain process and coping with psychosocial factors in the session will be completed by explaining the effect mechanisms of exercise on pain.
Study: NCT05925920

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ENT-03
Description: single dose of active drug

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single dose of placebo comparator
Study: NCT05176106

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHW Incentives Intervention
Description: The intervention comprises of an incentives package provided to VHTs who are active in the intervention-randomized parishes. It will comprise of items that will motivate them and support their work as VHTs in the community.
Study: NCT05167656

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intraoral manual therapy
Description: Six intraoral manual therapy sessions based on ischemic compression and pain pressure release of the temporomandibular region muscles, applied bilateral.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Extraoral manual therapy
Description: Six extraoral manual therapy sessions based on ischemic compression, pain pressure release and pressure sliding of the temporomandibular region muscles, applied bilateral.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise and counselling
Description: Information about etiology, contributing and related factors, natural history and prognostic of the pathology of temporomandibular disorders.~Counselling based on: diet, habits like tabacism, stress and anxiety control, physical activity and awareness of dental clenching.~Exercise daily program based on active and passive mobility of the temporomandibular joint, stretching exercises and self massage.
Study: NCT05237583

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Prehabilitation
Description: All participants will be offered a multimodal prehabilitation program. This program will include an individualized and supervised aerobic and resistance exercise training program, nutritional optimization, and psychological support. The program will last 6 months or until liver transplantation, whichever comes first.
Study: NCT06325215

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hidrocolloid Bant
Description: In this group, after the columella and nasal area of preterm infants were cleaned and dried with sterile water, hydrocolloid dressings were applied to the areas in contact with the nasal cannula. NasalNem nasal ointment was applied twice a day to the nasal passages in contact with the cannula. If the hydrocolloid dressings melted or peeled off, they were removed, the area was cleaned, and then reapplied.
Study: NCT05709847

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Coffee
Description: 24 ounces of coffee will be consumed daily

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Coffee
Description: 24 ounces of coffee will be consumed daily
Study: NCT05267912

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: We need a biopsy for PDO: PDOs are tridimensional multicellular structures expanded in vitro which retain the genotypic and phenotypic features of their tissue or tumor of origin. PDOs can be exposed to a panel of drugs (chemotherapy, hormonal therapy, targeted therapy) in order to study their sensitivity to each agent (or combination of agents) tested ('chemogram'). Recent studies showed that PDOs can accurately predict the response to treatment of solid tumors and could therefore inform clinical decision on the best therapeutic option for each patient.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: We need a biopsy for PDO: PDOs are tridimensional multicellular structures expanded in vitro which retain the genotypic and phenotypic features of their tissue or tumor of origin. PDOs can be exposed to a panel of drugs (chemotherapy, hormonal therapy, targeted therapy) in order to study their sensitivity to each agent (or combination of agents) tested ('chemogram'). Recent studies showed that PDOs can accurately predict the response to treatment of solid tumors and could therefore inform clinical decision on the best therapeutic option for each patient.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: We need a biopsy for PDO: PDOs are tridimensional multicellular structures expanded in vitro which retain the genotypic and phenotypic features of their tissue or tumor of origin. PDOs can be exposed to a panel of drugs (chemotherapy, hormonal therapy, targeted therapy) in order to study their sensitivity to each agent (or combination of agents) tested ('chemogram'). Recent studies showed that PDOs can accurately predict the response to treatment of solid tumors and could therefore inform clinical decision on the best therapeutic option for each patient.
Study: NCT02579187

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: clinical measurements
Description: After tooth extraction, clinical measurements of the site will be obtained and recorded (keratinized mucosa width, horizontal ridge width, facial and lingual bone thickness

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Biodegradable sponge (type I bovine collagen)
Description: control group subjects will receive a biodegradable sponge (type I bovine collagen) to stabilize the clot

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 10µg of pSil-miR200c
Description: subjects in the experimental group will receive a 10µg of pSil-miR200c plasmids in a biodegradable sponge (type I bovine collagen) to stabilize the clot

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cross mattress suture
Description: The site will be stabilized with a simplet external, cross mattress suture

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cross mattress suture
Description: The site will be stabilized with a simplet external, cross mattress suture
Study: NCT05167656

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise and counselling
Description: Information about etiology, contributing and related factors, natural history and prognostic of the pathology of temporomandibular disorders.~Counselling based on: diet, habits like tabacism, stress and anxiety control, physical activity and awareness of dental clenching.~Exercise daily program based on active and passive mobility of the temporomandibular joint, stretching exercises and self massage.
Study: NCT02579187

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cross mattress suture
Description: The site will be stabilized with a simplet external, cross mattress suture

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: cross mattress suture
Description: The site will be stabilized with a simplet external, cross mattress suture

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 10µg of PMIS miR200a plasmids
Description: subjects in the experimental group will receive a 10µg of PMIS miR200a plasmids in a biodegradable sponge (type I bovine collagen) to stabilize the clot

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5µg of pSil-miR200c and 5µg of PMIS miR200a
Description: subjects in the experimental group will receive a 5µg of pSil-miR200c and 5µg of PMIS miR200a plasmids in a biodegradable sponge (type I bovine collagen) to stabilize the clot

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood
Description: Subjects will have venipuncture performed to obtain a small blood sample (approx. 2 ml) to assess for miR-200c and PMIS-miR-200a expression and liver function (AST, ALT, bilirubin levels)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood
Description: Subjects will have venipuncture performed to obtain a small blood sample (approx. 2 ml) to assess for miR-200c and PMIS-miR-200a expression and liver function (AST, ALT, bilirubin levels)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Blood
Description: Subjects will have venipuncture performed to obtain a small blood sample (approx. 2 ml) to assess for miR-200c and PMIS-miR-200a expression and liver function (AST, ALT, bilirubin levels)

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Blood
Description: Subjects will have venipuncture performed to obtain a small blood sample (approx. 2 ml) to assess for miR-200c and PMIS-miR-200a expression and liver function (AST, ALT, bilirubin levels)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photos/videos
Description: subjects will have photos and/or videos of the extraction site and/or implant taken at each visit.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photos/videos
Description: subjects will have photos and/or videos of the extraction site and/or implant taken at each visit.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photos/videos
Description: subjects will have photos and/or videos of the extraction site and/or implant taken at each visit.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Photos/videos
Description: subjects will have photos and/or videos of the extraction site and/or implant taken at each visit.
Study: NCT04592809

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine Hydrochloride
Description: infused over a 40 minute period
Study: NCT02579187

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound fluid
Description: a small sample of wound fluid will be obtained from the extraction site in a minimally invasive manner using a paper point at 1, 2, 3 \& 4 weeks post extraction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound fluid
Description: a small sample of wound fluid will be obtained from the extraction site in a minimally invasive manner using a paper point at 1, 2, 3 \& 4 weeks post extraction
Study: NCT04592809

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine Hydrochloride
Description: infused over a 40 minute period

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam Hydrochloride
Description: infused over a 40 minute period

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Midazolam Hydrochloride
Description: infused over a 40 minute period
Study: NCT02579187

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wound fluid
Description: a small sample of wound fluid will be obtained from the extraction site in a minimally invasive manner using a paper point at 1, 2, 3 \& 4 weeks post extraction

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Wound fluid
Description: a small sample of wound fluid will be obtained from the extraction site in a minimally invasive manner using a paper point at 1, 2, 3 \& 4 weeks post extraction

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: saliva
Description: approximately 2 mls of saliva will be obtained in a minimally invasive manner at the time of extraction and at 14 weeks post extraction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: saliva
Description: approximately 2 mls of saliva will be obtained in a minimally invasive manner at the time of extraction and at 14 weeks post extraction.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: saliva
Description: approximately 2 mls of saliva will be obtained in a minimally invasive manner at the time of extraction and at 14 weeks post extraction.
Study: NCT05109819

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Esophagus sparring radiotherapy treatment
Description: A radiotherapy plan for metastatic spinal cord compression is conducted with specific constrains sparring the esophagus.
Study: NCT05625854

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blow a fan to the face combine aromatherapy
Description: Blow a fan with aromatherapy to the face

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Blow a fan to the face
Description: Blow a fan to the face

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Blow a fan to the feet
Description: Blow a fan to the feet
Study: NCT06512948

Intervention type: PROCEDURE
Intervention: High tibial osteotomy
Description: Surgical treatment for patients with osteoarthritis and indications for high tibial osteotomy
Study: NCT05797454

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wire-guided localization and marker clip localization
Description: Positioning guide wire and marker clip in the center of the lesion

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Wire-guided localization
Description: Positioning guide wire in the center of the lesion
Study: NCT05388591

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Musicotherapy
Description: Music listening with the application Music Care (style of music chosen by the patient) during wound suturing
Study: NCT05350566

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive leaf extract
Description: A capsule containing 250 mg of an olive leaf extract preparation will be swallowed with a glass of water before exercise.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Olive leaf extract
Description: A capsule containing 250 mg of an olive leaf extract preparation will be swallowed with a glass of water before exercise.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A capsule containing 336 mg of cellulose microcrystalline will be swallowed with a glass of water before exercise.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Placebo
Description: A capsule containing 336 mg of cellulose microcrystalline will be swallowed with a glass of water before exercise.
Study: NCT05217992

Intervention type: OTHER
Intervention: Genetic assessment (hemophilia testing)
Description: Determination of carrier ship of hemophilia with molecular tests
Study: NCT04923919

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anti-CLL1 CART cells
Description: In this study, patients with acute myeloid leukemia were treated with autologous anti-CLL1 CAR T cells by a single, intravenous infusion.Blood and bone marrow were collected before and 12 months after infusion to detect the number and activity of CAR T cells, and to evaluate the efficacy of CAR T cells.
Study: NCT04652583

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Earstim - Active Stimulation
Description: Intramuscular stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Earstim - Active Stimulation
Description: Intramuscular stimulation

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Earstim - Sham Stimulation
Description: Sham stimulation
Study: NCT05073562

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Iron and folic acid (IFA) supplementation
Description: Weekly IFA supplementation for duration of the study.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Targeted nutrition education
Description: Structured nutrition education package delivered at household level by trained Community Health Assistants (CHAs)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mebendazole Pill
Description: One-time deworming treatment with mebendazole.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard nutrition services
Description: Basic nutrition services currently provided at the health facility and at community level in Liberia